Welcome to AOHP 2015 National Conference Agenda page.
Start planning now to attend the 2015 AOHP National Conference in San Francisco from September 9-12, 2015. It is never too early to make plans and to ensure that your time and expenses are budgeted to attend. If you need help to justify your conference attendance with your supervisor, contact AOHP Headquarters for assistance in articulating the value at info@aohp.org.
Online Registration is now open www.aohpconference.com.
Conference official site Download conference brochure
View your personal schedule, browse what’s happening right now or search for what you want. The mobile web app stores the schedule data locally on your phone for offline access too. Bookmark on your phone by visiting http://aohp2015nationalconference.sched.org/mobile.
Topic Overview: The goal of this presentation is to educate occupational health professionals on the various tuberculosis (TB) tests available, and the operational and financial considerations for switching from one TB testing method to another. Specifically, the program will include an educational review of the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRAs,) including what they are, how they work and how they are used to screen for latent tuberculosis infection.
The presenters will discuss TB prevalence in the United States now and in the past, and they will introduce current diagnostic and treatment options for latent TB infection, focusing on the newer, blood-based IGRAs, some procedural considerations for screening programs and the importance of perspective and quantitative result interpretation. Current CDC screening recommendations and guidelines will be reviewed. Examples of screening programs in hospital, public health and Veterans Health Administration settings will be discussed, particularly in comparison with the previous standard of TST use. A toolkit with samples of policies and procedures will be shared.
The program will conclude with information about how participants can complete a financial assessment of the total cost of switching from one TB testing method to another at their institutions, with suggestions on how to present that information to other administrators and medical staff involved in the decision-making process.
Objectives: